Filtros de búsqueda

Lista de obras de

A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma

artículo científico publicado en 2016

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers.

artículo científico publicado en 2013

A diet low in fat and high in vegetables, fruit, and fiber following breast cancer treatment did not reduce new breast cancer events

artículo científico publicado en 2008

A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors

artículo científico publicado en 2013

A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer

artículo científico publicado en 2014

A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?

artículo científico publicado en 2008

A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities.

artículo científico publicado en 2010

A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin

artículo científico publicado en 2004

A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity

artículo científico publicado en 2004

A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia

artículo científico publicado en 2004

A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer

scientific article published on 01 January 2003

A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.

artículo científico publicado en 2010

A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer

artículo científico publicado en 2011

ACP Journal Club. Tamoxifen for 5 years reduced 16-year risk for breast cancer in women at increased risk

scientific article published on 01 May 2015

Activation of diverse signalling pathways by oncogenic PIK3CA mutations

artículo científico publicado en 2014

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

artículo científico publicado en 2003

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

artículo científico publicado en 2016

Adjuvant aromatase inhibitors and emerging quality-of-life considerations

scientific article published on 01 January 2008

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

artículo científico publicado en 2014

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

artículo científico publicado en 2014

Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins

artículo científico publicado en 2016

Advances in the adjuvant and neoadjuvant treatment of breast cancer

scientific article published on May 2007

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women

artículo científico publicado en 2009

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

artículo científico publicado en 2010

Approach to menopausal symptoms in women with breast cancer

artículo científico publicado en 2002

Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management ⬇️

artículo científico publicado el 14 de marzo de 2011

Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.

artículo científico publicado en 2008

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort

artículo científico publicado en 2009

Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

artículo científico publicado en 2015

Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover

artículo científico publicado en 2015

Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer

artículo científico publicado en 2013

Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants

artículo científico publicado en 2006

CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?

artículo científico publicado en 2018

CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients

artículo científico publicado en 2012

CYP2D6 genotype and tamoxifen response

artículo científico publicado en 2005

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

artículo científico publicado en 2005

CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance

artículo científico publicado en 2010

Can hypnosis reduce hot flashes in breast cancer survivors? A literature review

artículo científico publicado en 2004

Cancer support and resource needs among African American older adults ⬇️

artículo científico publicado el 1 de agosto de 2012

Centrally active nonhormonal hot flash therapies

artículo científico publicado en 2005

Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.

artículo científico publicado en 2011

Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond.

artículo científico publicado en 2006

Chemotherapeutic Strategies for advanced breast cancer

artículo científico publicado en 2007

Clinical update: new treatments for hot flushes

artículo científico publicado en 2007

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

artículo científico publicado en 2016

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

artículo científico publicado en 2011

Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.

artículo científico publicado en 2011

Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy

artículo científico publicado en 2009

Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report

artículo científico publicado en 2017

Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients

artículo científico publicado en 2010

Concordance of cancer patients' function, symptoms, and supportive care needs

artículo científico publicado en 2009

Cooling off hot flashes

artículo científico publicado en 2002

Current approaches for neoadjuvant chemotherapy in breast cancer

artículo científico publicado en 2013

DNA methylation-related vitamin D receptor insensitivity in breast cancer

artículo científico publicado en 2010

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood ⬇️

artículo científico publicado el 15 de marzo de 2012

Detection of cancer DNA in plasma of patients with early-stage breast cancer.

artículo científico publicado en 2014

Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses

artículo científico publicado en 2002

Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection.

artículo científico publicado en 2015

Disease-free survival was greater with letrozole than tamoxifen in postmenopausal women with early breast cancer

artículo científico publicado en 2006

Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer ⬇️

artículo científico publicado el 25 de febrero de 2011

Drug interactions and pharmacogenomics in the treatment of breast cancer and depression

artículo científico publicado en 2008

ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors

artículo científico publicado en 2016

Effect of simvastatin on the pharmacokinetics of anastrozole

scientific article published on 17 November 2011

Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial

artículo científico publicado en 2014

Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer

artículo científico publicado en 2016

Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies

artículo científico publicado en 2006

Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI

artículo científico publicado en 2007

Epigenetic regulation as a new target for breast cancer therapy

artículo científico publicado en 2007

Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response

artículo científico publicado en 2010

Epigenetics as a Therapeutic Target in Breast Cancer ⬇️

artículo científico publicado el 27 de julio de 2012

Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy

artículo científico publicado en 2008

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial

artículo científico publicado en 2013

Extended adjuvant therapy for breast cancer--how much is enough?

artículo científico publicado en 2007

Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer

artículo científico publicado en 2009

Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer

artículo científico publicado en 2013

Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk

artículo científico publicado en 2016

Gene Mutation Profiling of Breast Cancers for Clinical Decision Making: Drivers and Passengers in the Cart Before the Horse.

artículo científico publicado en 2015

Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

artículo científico publicado en 2016

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

artículo científico publicado en 2013

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

artículo científico publicado en 2010

Hot flushes

artículo científico publicado en 2002

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers.

scientific article published on February 2014

In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole ⬇️

artículo científico publicado el 1 de diciembre de 2010

Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk popul

artículo científico publicado en 2012

Intraductal therapy for the prevention of breast cancer

artículo científico publicado en 2010

Lipophilic statins merit additional study for breast cancer chemoprevention

artículo científico publicado en 2006

Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.

artículo científico publicado en 2006

Management of hot flashes in breast cancer survivors and men with prostate cancer

artículo científico publicado en 2004

Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer

artículo científico publicado en 2011

More choices, more questions: weighing the options for treating hot flashes

artículo científico publicado en 2006

Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors

Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment

artículo científico publicado en 2015

Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications.

artículo científico publicado en 2004

Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer

artículo científico publicado en 2010

Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support

artículo científico publicado en 2006

NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies

artículo científico publicado en 2014

Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30.

artículo científico publicado en 2010

Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions

artículo científico publicado en 2015

Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction

artículo científico publicado en 2014

Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer

artículo científico publicado en 2012

New therapeutic approaches for hot flashes in women

artículo científico publicado en 2003

Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration

scientific article published on September 2009

Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis

scientific article published on 30 March 2009

Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer ⬇️

artículo científico publicado el 27 de agosto de 2012

One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy ⬇️

artículo científico publicado el 13 de octubre de 2010

Optimizing vitamin D concentrations for breast cancer risk reduction

artículo científico publicado en 2013

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

artículo científico publicado en 2003

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

artículo científico publicado en 2005

Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer

artículo científico publicado en 2010

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer

artículo científico publicado en 2016

Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms

artículo científico publicado en 2013

Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

artículo científico publicado en 2014

Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy

scientific article published on 17 February 2010

Personalized tamoxifen: a step closer but miles to go

artículo científico publicado en 2010

Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?

artículo científico publicado en 2008

Pharmacogenetics of endocrine therapy for breast cancer

artículo científico publicado en 2011

Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?

artículo científico publicado en 2009

Pharmacogenomics of breast cancer therapy: an update

artículo científico publicado en 2013

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer

artículo científico publicado en 2013

Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors

artículo científico publicado en 2007

Postmenopausal hormone receptor-positive advanced breast cancer

artículo científico publicado en 2013

Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer ⬇️

artículo científico publicado el 15 de mayo de 2011

Preclinical and Clinical Evaluation of Intraductally Administered Agents in Early Breast Cancer ⬇️

artículo científico publicado el 26 de octubre de 2011

Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer

artículo científico publicado en 2012

Preferences for hypnotic imagery for hot-flash reduction: a brief communication

scientific article published on 01 July 2010

Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors

artículo científico publicado en 2017

Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

artículo científico publicado en 2007

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment

scientific article published on 01 July 2006

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial

artículo científico publicado en 2012

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.

artículo científico publicado en 2018

Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk

artículo científico publicado en 2006

Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk

artículo científico publicado en 2006

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

artículo científico publicado en 2017

Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.

artículo científico publicado en 2008

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

artículo científico publicado en 2006

Reply to J.L. Blum et al and S. Lange et al.

artículo científico publicado en 2017

Reply to K.I. Pritchard

artículo científico publicado en 2013

Role of CYP2D6 testing in selection of endocrine therapy for breast cancer

artículo científico publicado en 2007

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer

artículo científico publicado en 2002

Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms

artículo científico publicado en 2006

Severe prolonged cholestatic hepatitis caused by exemestane

artículo científico publicado en 2009

Statins and Breast Cancer: Future Directions in Chemoprevention

scientific article published on September 2013

Survivorship care visits in a high-risk population of breast cancer survivors

artículo científico publicado en 2018

Symptoms, supportive care needs, and function in cancer patients: how are they related?

artículo científico publicado en 2008

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

artículo científico publicado en 2014

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

artículo científico publicado en 2015

Tamoxifen metabolism and its effect on endocrine treatment of breast cancer.

artículo científico publicado en 2009

Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.

artículo científico publicado en 2015

The biology of hormone refractory breast and prostate cancer: An NCI workshop report

artículo científico publicado en 2009

The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

artículo científico publicado en 2016

Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation

artículo científico publicado en 2009

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells

artículo científico publicado en 2012

Treatment strategies for hot flushes

artículo científico publicado en 2009

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

artículo científico publicado en 2014

Treatment-emergent effects may predict benefit from endocrine therapy

artículo científico publicado en 2013

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.

artículo científico publicado en 2017

Understanding resistance to tamoxifen in hormone receptor-positive breast cancer.

artículo científico publicado en 2009

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

artículo científico

Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged ≥70 Years With Hormone Receptor-Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative

artículo científico publicado en 2017

Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients

article published in 2017

Whole Genome Amplification of DNA for Genotyping Pharmacogenetics Candidate Genes ⬇️

artículo científico publicado el 30 de marzo de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda